Ladarixin, a dual CXCR1/2 inhibitor, attenuates experimental melanomas harboring different molecular defects by affecting malignant cells and tumor microenvironment

por Kemp, Daria Marley, Pidich, Alyson, Larijani, Mary, Jonas, Rebecca, Lash, Elizabeth, Sato, Takami, Terai, Mizue, Pizzol, Maria De, Allegretti, Marcello, Igoucheva, Olga, Alexeev, Vitali
Publicado 2017